Eli Lilly’s Oral GLP-1 Foundayo Trails Novo Nordisk’s Wegovy Pill in Early Obesity Launch Uptake, According to Spherix Global Insights

Despite a more flexible administration profile, Foundayo generated lower first-month prescribing rates than the Wegovy Pill ...